Other languages Eli Lilly and Company Xetra

Equities

Real-time Estimate Tradegate Other stock markets 13:21:16 17/07/2024 BST			5-day change	1st Jan Change
828.6 ^EUR	-5.00%		-4.55%	+57.29%

11:11am	ANALYST RECOMMENDATIONS : American Airlines, Chevron, UnitedHealth, Bank of America, Eli Lilly...
08:13am	Roche reports positive early results in obesity drug trial	RE

Roche Holding AG: Als der Markt Roche mit Novo Nordisk verwechselte...	11:56am
Cuando el mercado se lleva a Roche por Novo Nordisk	10:31am
Roche treibt Entwicklung von Abnehmpille nach positiven Daten voran	09:53am
Quand le marché prend Roche pour Novo Nordisk	09:03am
Roche reports positive early results in obesity drug trial	07:13am
Aclaris Therapeutics Sells Olumiant Royalties, Milestone Payments From Eli Lilly	07-16
Novo owner backs Swiss biotech Asceneuron in $100 million round	07-16
DexCom, Inc. : Una herramienta imprescindible para el cuidado de la diabetes	07-15
Novo Nordisk faces scrutiny on Capitol Hill for pulling Levemir insulin from US market	07-12
Ozempic linked with lower dementia risk, nicotine use, British study finds	07-12
Patients on weight-loss drugs should inform doctor before surgery, EU regulator says	07-12
Pharmariese Pfizer startet neuen Anlauf mit Abnehmpille	07-11
Pfizer avanza en una píldora diaria para adelgazar	07-11
Pfizer moves forward with once-daily weight loss drug	07-11
US Senator Sanders optimistic Novo Nordisk can be pressured to cut Wegovy, Ozempic prices	07-10
SANDERS SAYS HE IS CURRENTLY FOCUSED ON NOVO NORDISK BUT WILL 'C…	07-10
Eli Lilly Names Gordon Brooks Interim CFO	07-10
Eli Lilly and Company Announces Resignation of Anat Ashkenazi Resigned as Executive Vice President	07-10
Analysis Shows Use of Novo Nordisk's Wegovy, Ozempic for Weight Loss Declines After Two Years	07-10
Studie - Übergewichtige setzen nicht lange auf Abnehmspritzen	07-10

No results for this search

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 12, 2024 at 06:47 pm